LOI, SARA

LOI, SARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons 2023 Galassi, LucaAntonelli, AlessandroGiuliani, BeatriceChierici, AndreaCentonze, LeonardoLauterio, AndreaGiurazza, GiancarloMele, CaterinaMicalef, AndreaSettembrini, AlbertoMei, SimonaCarbone, GabrieleOttaviani, LucaEpifani, Angelo GabrieleMaffioli, AnnaMoretti, MarcoUggeri, FabioIacopino, GiorgiaDi Pietro, FrancescoDamarco, FrancescoLoi, SaraMicheletto, GiancarloOrlandi, RiccardoMendogni, PaoloSena, GiuseppeMarchetto, CarloBenuzzi, LauraBracchetti, GretaBrucchi, FrancescoManzo, Carlo AlbertoScaravilli, LucaGrande, SimonaFrancia, AlessandroBaia, Marco + Article (author) -
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis 2022 Curigliano G.Loi S. + Article (author) -
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer 2020 Loi S.Curigliano G. + Article (author) -
Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC) 2018 Vingiani, ACurigliano, GLoi, S + Article (author) -